Pharmacists in North Charleston, South Carolina
112 Pharmacists found in North Charleston
Dr. Laurie Trinh, PHARM.D
Pharmacist
7250 Rivers Ave, Target 1829, North Charleston, SC 29406
843-572-8918 843-572-8918
Dr. Lindsey Osterfeld Cashwell, PHARMD
Pharmacist
9330 Medical Plaza Dr, North Charleston, SC 29406
843-847-4155
Lisa Floyd Harle, R.PH.
Pharmacist
3725 Rivers Ave Ste 2, North Charleston, SC 29405
843-745-8635 843-747-6841
Lorian Simmons, PHARM D
Pharmacist
3600 Rivers Ave, North Charleston, SC 29405
843-743-7868 843-743-7521
Dr. Marcie Hudgins Mitchell, PHARMD
Pharmacist
8995 University Blvd, North Charleston, SC 29406
843-414-0710 843-414-0714
Dr. Marjorie Schultz Dales, PHARMD
Pharmacist
7771 Palmetto Commerce Pkwy Rm 404, North Charleston, SC 29420
843-876-7074
Mr. Mark Anthony Burgess, RPH
Pharmacist
3725 Rivers Ave, Suite 2, North Charleston, SC 29405
843-745-8647
Dr. Michael Anthony Mezzadri, PHARM D, RPH
Pharmacist
5215 Ashley Phosphate Rd, North Charleston, SC 29418
843-767-4500
Pamea Jacinda Mazyck, PHARMD
Pharmacist
8395 Dorchester Rd, Store 6076, North Charleston, SC 29418
843-207-1578
Dr. Pamela Ann Oloughlin, PHARMACIST
Pharmacist
3600 Rivers Ave, North Charleston, SC 29405
843-743-7868 843-743-7521
Patricia Kaye Hudgens, PHARM.D.
Pharmacist
3725 Rivers Ave, Suite 2, North Charleston, SC 29405
843-745-8630
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.